我要投票 片仔癀药业在医疗保健行业中的票数:208
· 外 推 电 报 ·
2025-04-20 02:27:08 星期日

【片仔癀药业是哪个国家的品牌?】

片仔癀药业是什么牌子?「片仔癀药业」是 漳州片仔癀药业股份有限公司 旗下著名品牌。该品牌发源于福建,由创始人刘建顺在1555期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力片仔癀药业品牌出海!通过在本页面挂载片仔癀药业品牌的产品链接和联系邮箱,可以提高片仔癀药业产品曝光!跨境电商爆单神器,目前只要100元/年哦~

漳州片仔癀药业股份有限公司,是漳州市制药厂改制创立的,是全国“重合同、守信用”企业、国家火炬高新技术企业、福建省百家重点工业企业、居我国中成药行业50强。公司连续多年入选福建省工业主要行业竞争力十强、工业300强、工业效益300强、利税300强。公司以生产名贵中成药——片仔癀而享誉海内外,注册的“片仔癀”商标于1999年元月被评为“中国驰名商标”,2006年入选商务部首批“中华老字号”、并入选中华老字号品牌价值百强榜20强,福建省出口名牌,片仔癀系列产品首批通过国家原产地标记认证,并被评为福建省名牌产品。2002年经国家人事部批准,设立博士后科研工作站。公司股票于2003年6月16日在上海证券交易所成功上市,2003年度列全国1200多家上市公司综合绩效排名第11位,2004年被评为福建省大、中型国有及国有控股企业效绩“十佳”。

公司的主导产品——片仔癀,两度荣获国家质量金质奖,并被列入国家中药一级保护品种,其以独特的消炎、解毒、镇痛、保肝等显著疗效及保护健康的功能而深受国内外患者的赞誉,被誉为“国宝神药”,并大量出口东南亚、日本、韩国、加拿大等国家和地区,年出口创汇超千万美元,居中国中成药单项出口创汇首位。2000年片仔癀作为内地第一个获得香港政府创新及科技基金无偿资助的中成药研究项目,由香港中文大学进行片仔癀保肝作用研究。

公司视产品质量为企业的生命,严格按国家GMP规范要求组织生产。公司始终重视新药的研发和老产品二次开发工作。近年来,相继研制开发投产了包括金糖宁胶囊、心舒宝片、清热止咳颗粒、复方片仔癀含片、增乳膏等在内的十几个新产品,使公司每年都有新产品面市,老产品二次开发--片仔癀胶囊增加适应症的临床研究被国家列入“863”计划。

目前公司有如下几个系列产品:

1.片仔癀系列:片仔癀、片仔癀胶囊、复方片仔癀软膏、复方片仔癀痔疮软膏、复方片仔癀含片;

2.感冒止咳系列:清热止咳颗粒、川贝清肺糖浆、藿香正气水(胶囊)、金牡感冒片、小柴胡颗粒、板蓝根颗粒、小儿止咳糖浆等;

3.丸剂系列:六味地黄丸、杞菊地黄丸、知柏地黄丸、香砂六君丸、逍遥丸;

4.保肝护肝类:茵胆平肝胶囊、护肝片;

5.妇女儿童类:增乳膏、逍遥丸、小儿止咳糖浆;

6.心血管类:心舒宝片、复方丹参片;

7.其它:少林正骨精、牛黄解毒片、蜂乳胶囊、金糖宁胶囊等等;

8.另外还有仅供国外销售产品:龙江牌特效片仔癀暗疮膏、复方片仔癀肝宝、片仔癀活络油、片仔癀白花蛇解痒片、片仔癀润喉片、片仔癀消炎胶囊、片仔癀润喉糖、片仔癀跌打精等。

英文翻译:Zhangzhou Pianzihuang Pharmaceutical Co., Ltd. was founded by Zhangzhou pharmaceutical factory. It is a national "contract and credit" enterprise, a national torch high-tech enterprise, a hundred key industrial enterprises in Fujian Province, and one of the top 50 Chinese patent medicine enterprises in China. For many years, the company has been selected as one of the top ten industrial competitiveness, top 300 industry, top 300 industrial efficiency and top 300 profit and tax. The company is famous at home and abroad for the production of famous Chinese patent medicine - pianzehuang. The registered "pianzehuang" trademark was rated as "China's famous trademark" in January 1999. In 2006, it was selected as the first batch of "China's time-honored brand" by the Ministry of Commerce, and was listed as the top 20 in the top 100 brand value list of China's time-honored brand. Fujian Province's export famous brand, pianzehuang series of products passed the national origin mark certification in the first batch, and was evaluated It is a famous brand product in Fujian Province. In 2002, with the approval of the Ministry of personnel of the people's Republic of China, a postdoctoral research station was established. The company's shares were successfully listed on the Shanghai Stock Exchange on June 16, 2003. In 2003, it ranked 11th in the comprehensive performance of more than 1200 listed companies in China. In 2004, it was rated as the "top ten" performance of large, medium-sized state-owned and state-owned holding enterprises in Fujian Province. The company's leading product, pianzehuang, has twice won the national quality gold medal and has been listed in the first level national protection of traditional Chinese medicine. It is highly praised by patients at home and abroad for its unique anti-inflammatory, detoxification, analgesic, liver protection and other remarkable curative effects and health protection functions. It is known as the "national treasure drug" and exported to Southeast Asia, Japan, South Korea, Canada and other countries and regions, The annual export earnings exceed ten million US dollars, ranking first in the single export earnings of Chinese patent medicine. In 2000, as the first Chinese patent medicine research project funded by the Hong Kong government innovation and science and technology fund, the Chinese University of Hong Kong carried out the research on the liver protection effect of Pianzihuang. The company regards product quality as the life of the enterprise and organizes production in strict accordance with the requirements of GMP. The company always attaches great importance to the research and development of new drugs and the secondary development of old products. In recent years, more than ten new products including Jintangning capsule, Xinshubao tablet, Qingre Zhike granules, compound Pianzihuang buccal tablet, Zengyao and so on have been developed and put into production successively, which makes the company have new products on the market every year. The second development of old products -- clinical research on the indication of increasing Pianzihuang capsule has been listed in the "863" plan by the state. At present, the company has the following series of products: 1. Pianzihuang series: Pianzihuang, Pianzihuang capsule, compound Pianzihuang ointment, compound Pianzihuang hemorrhoids ointment, compound Pianzihuang buccal tablet; 2. Cold and cough series: Qingre Zhike granules, Chuanbei Qingfei syrup, Huoxiang Zhengqi water (capsule), Jinmu cold tablet, Xiaochaihu granules, Banlangen Granules, Xiaoer Zhike syrup, etc.; 3. Pills Series: Liuwei Dihuang pill, Qiju Dihuang pill, Zhibai Dihuang pill, Xiangsha Liujun pill, Xiaoyao Pill; 4. Liver protection and liver protection: yindanpinggan capsule, Hugan tablet; 5. Women and children: Zengyao, Xiaoyao Pill, Xiaoer cough syrup; 6. Cardiovascular: Xinshubao tablet, Fufang Danshen tablet; 7. Others: Shaolin zhenggujing, Niuhuang Jiedu tablet, bee milk capsule, Jintangning capsule, etc.; 8 In addition, there are only foreign products for sale: Longjiang brand special effect pianzehuang acne cream, compound pianzehuang Ganbao, pianzehuang Huoluo oil, pianzehuang Baihua snake antipruritic tablet, pianzehuang Runhou tablet, pianzehuang Xiaoyan capsule, pianzehuang Runhou sugar, pianzehuang drop hit essence, etc.

本文链接: https://www.waitui.com/brand/5a0277eda.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

后视摄像头图像无法显示,克莱斯勒在美召回48494辆汽车

当地时间4月19日,美国国家公路交通安全管理局(NHTSA)文件披露,由于显示模块可能无法显示后视摄像头图像,克莱斯勒将召回部分2023-2025年款阿尔法·罗密欧Tonale托纳利和道奇大黄蜂,共计48494辆。(界面)

28分钟前

一季度北京地区进出口7198.9亿元 汽车产业拉动出口增长

4月19日,据北京海关消息,今年一季度北京地区(含中央在京单位)进出口7198.9亿元。其中,出口1480.9亿元,较去年同期增长2.2%。北京外贸含“新”量进一步提升。一季度,北京地区汽车产业出口128.1亿元,同比增长56%,上拉同期地区出口增速3.2个百分点,拉动作用最强。同期,医药健康产业、绿色低碳产业分别出口31.6亿元、19亿元,同比分别增长5.8%、119.1%。

28分钟前

上海国际集团与宝山区签署战略合作框架协议 支持绿色低碳、新材料、机器人等发展

4月19日,上海国际集团与宝山区签署战略合作框架协议。双方将通过北转型基金提级扩募,重点支持宝山绿色低碳、新材料、机器人及智能制造等主导产业发展,以全链条金融服务赋能科创产业升级,并加强上市平台培育。(财联社)

28分钟前

一季度重庆外贸进出口总值1651.4亿元 同比增长4.1%

4月19日,重庆海关发布消息称,2025年一季度,重庆外贸进出口总值为1651.4亿元(人民币,下同),同比增长4.1%。据重庆海关介绍,2025年一季度,东盟是重庆第一大贸易伙伴,进出口281.4亿元,同比增长10.5%。此外,重庆对拉美、中东、非洲等新兴市场分别同比增长30.9%、9.2%、41.2%,外贸“朋友圈”持续扩大。

28分钟前

改善患者肢体运动功能 “植入式迷走神经刺激系统”临床试验启动

4月19日,国家卫生健康委组织实施“百万减残”工程重点推广项目,我国自主研发的“植入式迷走神经刺激系统”临床试验正式全国启动。该项目有望成为我国卒中后残疾防控的重要手段。迷走神经电刺激作为一种微创手术,可以辅助脑卒中患者康复治疗。数据显示,该技术能够在卒中后康复黄金期6月以后,帮助患者持续重建神经功能,明显改善患侧肢体运动功能。(财联社)

28分钟前

本页详细列出关于MCKESSON麦克森的品牌信息,含品牌所属公司介绍,MCKESSON麦克森所处行业的品牌地位及优势。
咨询